Description of Medical Areas
About the FDA Approved Listings
|
 |
Drugs Approved by the FDA (1995)
|
The following drugs have been approved this year by
the Food and Drug Administration.
Cardiology/Vascular Diseases
|
|
Dental/Maxillofacial Surgery
|
|
Dermatology/Plastic Surgery
|
|
Renova (tretinoin emollient cream); Treatment for facial wrinkles, brown spots, and surface roughness associated with chronic sun exposure; Johnson & Johnson; Approved December 1995
Amaryl (Glimepiride); Treatment for type II diabetes; Hoechst Marion Roussel; Approved December 1995 Epivir (lamivudine); Treatment used in combination with AZT for AIDS/HIV infection; GlaxoWellcome; Approved on November 17, 1995 Ethyol (amifostine); Treatment to reduce renal toxicity associated with chemotherapy in subjects with advanced ovarian cancer; Alza, U.S. Bioscience; Approved December 8, 1995 Fosamax (alendronate sodium); Treatment for osteoporosis in women after menopause and Paget's Disease of Bone; Merck; Approved on September 29, 1995 Leukine (sargramostim); Treatment for mobilizing peripheral blood progenitor cells for use after transplantation.; Immunex; Approved on November 24, 1995 Precose (acarbose); Treatment for non-insulin-dependent diabetes mellitus; Bayer; Approved September 6, 1995
Immunology/Infectious Diseases
|
|
Cedax (ceftibuten); Treatment for chronic bronchitis, acute bacterial otitis media, pharyngitis/tonsillitis; Schering-Plough; Approved December 1995 Clarithromycin (Biaxin); Treatment for the prevention of disseminated Mycobacterium avium complex (MAC); Abbott Laboratories; Approved December 1995 Epivir (lamivudine); Treatment used in combination with AZT for AIDS/HIV infection; GlaxoWellcome; Approved on November 17, 1995 Zerit (stavudine); Treatment for HIV-infected adults who are intolerant of approved therapies; Bristol-Myers Squibb; Approved December 22, 1995 Zyrtec (cetirizine HCl); Treatment for year-round allergies, seasonal allergic rhinitis, and chronic itching and hives; Pfizer; Approved December 1995
Fosamax (alendronate sodium); Treatment for osteoporosis in women after menopause and Paget's Disease of Bone; Merck; Approved on September 29, 1995
Rilutek (riluzole); Treatment for amyotrophic lateral sclerosis (ALS); Rhone Poulenc Rorer; Approved December 1995
Ethyol (amifostine); Treatment to reduce renal toxicity associated with chemotherapy in subjects with advanced ovarian cancer; Alza, U.S. Bioscience; Approved December 8, 1995 Fosamax (alendronate sodium); Treatment for osteoporosis in women after menopause and Paget's Disease of Bone; Merck; Approved on September 29, 1995
Ethyol (amifostine); Treatment to reduce renal toxicity associated with chemotherapy in subjects with advanced ovarian cancer; Alza, U.S. Bioscience; Approved December 8, 1995 Leukine (sargramostim); Treatment for mobilizing peripheral blood progenitor cells for use after transplantation.; Immunex; Approved on November 24, 1995
Cedax (ceftibuten); Treatment for chronic bronchitis, acute bacterial otitis media, pharyngitis/tonsillitis; Schering-Plough; Approved December 1995
Pulmonary/Respiratory Diseases
|
|
Cedax (ceftibuten); Treatment for chronic bronchitis, acute bacterial otitis media, pharyngitis/tonsillitis; Schering-Plough; Approved December 1995 Zyrtec (cetirizine HCl); Treatment for year-round allergies, seasonal allergic rhinitis, and chronic itching and hives; Pfizer; Approved December 1995
Trauma/Emergency Medicine
|
|
|
|
Back to Centerwatch Drug Directories
|
